search
Back to results

The National Lipedema Study

Primary Purpose

Lipedema

Status
Recruiting
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Liposuction early
Liposuction late
Standard conservative treatment
Standard conservative treatment with Intermittent Pneumatic Compression (IPC)
Sponsored by
Haraldsplass Deaconess Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Lipedema focused on measuring Liposuction, Conservative treatment, Intermittent pneumatic compression, Lipoedema, Compression therapy, Self management, Dietary management

Eligibility Criteria

20 Years - 65 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • female
  • age 20-65 years
  • significant pain from lipedema
  • lipedema stage 1-2 or localized stage 3

Exclusion Criteria:

  • Non-fluency in the Norwegian language
  • pregnancy
  • current malignancy
  • previous surgical treatment for lipedema
  • smoking
  • BMI > 28
  • serious comorbidities such as cardiac-, pulmonary-, renal disease
  • unwillingness to wear compression garments

Sites / Locations

  • Haraldsplass Deaconess HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Experimental

Experimental

Active Comparator

Arm Label

Standard conservative treatment

Standard treatment plus additional lymphedema treatment

Surgical group: Liposuction

Srugical group: Control

Arm Description

Standard Conservative treatment consisiting of: Physical therapy, includng Compression garment and exercise program Self-care program Individual counseling from a clinical dietician

Standard Conservative treatment consisiting of: Physical therapy, includng Compression garment and exercise program Self-care program Individual counseling from a clinical dietician Additional lymphedema treatment consising of intermittent pneumatic compression (IPC)

Early liposuction, 6-9 months after inclusion in study.

Late liposuction, 18-21 months after inclusion. This group functions as a control group for 1 year before enrolment in the Liposuction group.

Outcomes

Primary Outcome Measures

Effect of liposuction on lipedema pain
Assess the effect of liposuction on lipedema pain (Visual Analog Scale (VAS)).

Secondary Outcome Measures

Effect of liposuction on quality of life and everyday activities for patients with lipedema
Assess the effect of liposuction on quality of life and everyday activities (RAND-36)

Full Information

First Posted
March 8, 2022
Last Updated
March 8, 2022
Sponsor
Haraldsplass Deaconess Hospital
Collaborators
St. Olavs Hospital, University Hospital of North Norway, Sykehuset Telemark, University of Bergen, Klinbeforsk, Helse Vest
search

1. Study Identification

Unique Protocol Identification Number
NCT05284266
Brief Title
The National Lipedema Study
Official Title
Surical Treatment of Lipedema in Norway - a National Multicenter Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
March 11, 2022 (Anticipated)
Primary Completion Date
December 31, 2025 (Anticipated)
Study Completion Date
December 31, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Haraldsplass Deaconess Hospital
Collaborators
St. Olavs Hospital, University Hospital of North Norway, Sykehuset Telemark, University of Bergen, Klinbeforsk, Helse Vest

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Lipedema is a chronic condition with a symmetrical accumulation of painful fatty tissue primarily affecting the limbs, sparing hands, feet and trunk. The subcutaneous fatty tissue is disproportionately voluminous and may have a different microstructure and metabolism than the patient's regular fatty tissue. The condition affects almost exclusively women and usually debuts around puberty. Lipedema seems to have a hereditary component, may be affected by hormonal variations and worsens with obesity. Guidelines advocate conservative treatment with compression therapy, weight management, physical activity, life style changes and psychological support;and in some cases surgical treatment such as bariatric surgery and liposuction. Treatment of lipedema is indicated when the condition causes significant pain and inhibits the patient's everyday activities. Well-designed randomized controlled studies on lipedema are lacking. The Ministry of Health and Care Services in Norway has found the scientific documentation for the effects of liposuction to be insufficient and has recommended that surgical treatment of lipedema should be evaluated through a 5-year clinical trial. A national task force, consisting of representatives from all four regional health authorities in Norway has been set up. This task force has now initiated this study. A national multi-center study with homogenous treatment protocols can provide globally sought insight on lipedemaand the effect of its treatment regimes, and the findings will be important to adjust future treatment strategies regarding both effect and cost/effectiveness.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lipedema
Keywords
Liposuction, Conservative treatment, Intermittent pneumatic compression, Lipoedema, Compression therapy, Self management, Dietary management

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Eligible patients are randomized to two different conservative treatment protocols;either standard conservative treatment (SCT) or standard treatment plus additional lymphedema treatment (intermittent pneumatic compression -IPC). After 6 months the effects of the conservative treatment areevaluated. Patients who still want surgery and fulfill the criteria are randomized (1:1) to early (cases(liposuction initiated 6-9 months after inclusion)) or late surgery (controls (liposuction initiated 18-21 months after inclusion)). Randomization to the surgical group is stratified by conservative treatment arm.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
220 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard conservative treatment
Arm Type
Active Comparator
Arm Description
Standard Conservative treatment consisiting of: Physical therapy, includng Compression garment and exercise program Self-care program Individual counseling from a clinical dietician
Arm Title
Standard treatment plus additional lymphedema treatment
Arm Type
Experimental
Arm Description
Standard Conservative treatment consisiting of: Physical therapy, includng Compression garment and exercise program Self-care program Individual counseling from a clinical dietician Additional lymphedema treatment consising of intermittent pneumatic compression (IPC)
Arm Title
Surgical group: Liposuction
Arm Type
Experimental
Arm Description
Early liposuction, 6-9 months after inclusion in study.
Arm Title
Srugical group: Control
Arm Type
Active Comparator
Arm Description
Late liposuction, 18-21 months after inclusion. This group functions as a control group for 1 year before enrolment in the Liposuction group.
Intervention Type
Procedure
Intervention Name(s)
Liposuction early
Intervention Description
Liposuction 6-9 months after inclusion
Intervention Type
Procedure
Intervention Name(s)
Liposuction late
Intervention Description
Liposuction 18-21 months after inclusion
Intervention Type
Other
Intervention Name(s)
Standard conservative treatment
Intervention Description
Standard Conservative treatment consisiting of: Physical therapy, including compression garment and exercise program, Self-care program
Intervention Type
Other
Intervention Name(s)
Standard conservative treatment with Intermittent Pneumatic Compression (IPC)
Intervention Description
Physical therapy, including compression garment and exercise program, Self-care program and Intermittent Pneumatic Compression (IPC)
Primary Outcome Measure Information:
Title
Effect of liposuction on lipedema pain
Description
Assess the effect of liposuction on lipedema pain (Visual Analog Scale (VAS)).
Time Frame
12 months after the last liposuction surgery
Secondary Outcome Measure Information:
Title
Effect of liposuction on quality of life and everyday activities for patients with lipedema
Description
Assess the effect of liposuction on quality of life and everyday activities (RAND-36)
Time Frame
12 months after the last liposuction surgery
Other Pre-specified Outcome Measures:
Title
Effect of different conservative treatments on lipedema pain and quality of life and everyday activites for patients with lipedema
Description
Effect of two different conservative treatments strategies on pain and everyday activities(RAND-36)
Time Frame
6 monts after inclusin
Title
Adverse effect of liposuction
Description
Asses possible adverse effects of liposuction and
Time Frame
12 months after last liposuction surgery
Title
Effect of liposuction on the need for conservative treatment
Description
Assess whether having undergone liposuction reduces the need for conservative treatment.
Time Frame
3 years after last liposuction surgery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: female age 20-65 years significant pain from lipedema lipedema stage 1-2 or localized stage 3 Exclusion Criteria: Non-fluency in the Norwegian language pregnancy current malignancy previous surgical treatment for lipedema smoking BMI > 28 serious comorbidities such as cardiac-, pulmonary-, renal disease unwillingness to wear compression garments
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Aslaug Drotningsvik, PhD
Phone
55978626
Ext
0047
Email
aslaug.drotningsvik@haraldsplass.no
First Name & Middle Initial & Last Name or Official Title & Degree
Hildur Skuladottir, PhD
Phone
55978689
Ext
0047
Email
hildur.skuladottir@haraldsplass.no
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hildur Skuladottir, PhD
Organizational Affiliation
Haraldsplass Deaconess Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Haraldsplass Deaconess Hospital
City
Bergen
ZIP/Postal Code
5009
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Aslaug Drotningsvik, PhD
Phone
55978626
Ext
0047
Email
aslaug.drotningsvik@haraldsplass.no

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Data will be available after publication of outcomes.
IPD Sharing Time Frame
Data will be available after publication of outcomes.

Learn more about this trial

The National Lipedema Study

We'll reach out to this number within 24 hrs